Systemic Inflammation: A Predictor of Gait Decline

Published on April 12, 2022

Imagine your body as a long-distance runner, gracefully striding through the years. But what if there were an unseen hurdle waiting to trip you up? A recent study delved into the relationship between inflammation markers and gait speed, a key indicator of aging. The findings revealed that higher levels of systemic inflammation, measured two decades earlier, were associated with slower gait speed in community-dwelling adults. This connection remained even after accounting for age, cardiometabolic factors, and executive functions. While the exact mechanism is still being unraveled, it suggests that systemic inflammation could be an early warning sign for future declines in gait performance. Just like a roadside caution sign helps drivers prepare for upcoming hazards, monitoring inflammation levels may help identify individuals at risk of gait decline. To learn more about this fascinating research, lace up your sneakers and head over to the full article!

BackgroundGait speed, a central marker of aging, has been linked to various health outcomes, such as cognitive and physical functions in middle-aged adults. Although long-term systemic low-grade inflammation is considered a mechanism underlying a variety of aging-related risk factors, the longitudinal associations between inflammation markers and gait speed are yet to be fully investigated.ObjectiveTo explore the associations of CRP and fibrinogen levels, measured two decades ago, with gait speed among community dwelling adults, considering the contribution of cardio-metabolic factors and cognition.MethodsStudy participants took part in two phases of the of the “Kibbutzim Family Study” (i.e., Phase II, 1999–2000 and Phase III, 2017–2019). Blood samples collected in Phase II (baseline) were used to determine level of inflammatory markers. Gait speed was assessed under single-task (ST) and dual-task (DT) conditions in Phase III. Demographic, anthropometric and clinical data were collected in both phases. Linear regression models were used to assess the adjusted associations of inflammation and gait speed.ResultsA total of 373 individuals aged 34–99 (mean 64 ± 13 years) in Phase III were included in the study. Gait speed under ST was negatively associated with baseline levels of fibrinogen (b per standard deviation (SD) = −0.053, p = 0.0007) and CRP (b per SD = −0.043, p = 0.010), after adjusting for baseline and concurrent cardiometabolic risk factors. Accounting for executive functions, associations of fibrinogen with gait under ST were somewhat attenuated, yet associations remained statistically significant (p < 0.05). Associations with CRP were attenuated to the null. In contrast, there were no associations between inflammation markers and gait under DT.ConclusionOur findings demonstrate that in a sample including younger to older adults, higher systemic inflammatory activity was linked with gait 20 years later, beyond age and cardiometabolic health, and to a certain extent, beyond executive functions. Thus, systemic inflammation may serve as an early marker to identify individuals at risk for gait decline.

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>